OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IN PROLONGED DEEP REMISSION: POTENTIAL IMPLICATIONS ON DE-ESCALATION STRATEGIES IN A REAL LIFE CLINICAL SETTING WITHOUT A THERAPEUTIC DRUG MONITORING (TDM) APPROACH
Saved in:
Published in | Digestive and liver disease Vol. 51; p. e101 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
25.03.2019
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 1590-8658 1878-3562 |
---|---|
DOI: | 10.1016/S1590-8658(19)30185-9 |